北交所策略专题报告 2025 年 08 月 25 日 卓兆点胶收购广东浦森，设备与耗材强强联合客户互补，中报扭亏为盈 ——北交所策略并购专题报告第五期 北交所研究团队 诸海滨（分析师） zhuhaibin@kysec.cn 证书编号：S0790522080007 政策鼓励北交所并购，前期并购事件推进中 从新"国九条"到"并购六条"，2024 年起，并购重组市场迎来了诸多积极信号。 产业整合、跨界并购，为产业发展注入了新的动力。此外，地方国资成立并购基 金的步伐也在加快，交易设计方面的创新层出不穷，上市公司亦借助并购重组的 力量积极拓展国际市场。定位为主要服务创新型中小企业的北交所，能够及时把 握并购机遇。我们认为，在北交所公司并购的趋势方向上，应重点关注：（1）同 一集团内优质资源整合；（2）新质生产力行业外延并购；（3）"强链补链"扩张 版图式并购。截至 2025 年 8 月 24 日，北交所共发生 32 家次重要投资并购事件。 卓兆点胶收购广东浦森 51%股权，是 "设备+耗材"协同并购的标杆案例 （1）交易设计：全资子公司苏州卓兆自动化科技有限公司以人民币 9,690 万元 收购广东浦森塑胶科技有限公司 ...

Core Insights - As of August 17, 25 companies listed on the Beijing Stock Exchange disclosed their 2025 semi-annual reports, with 22 companies reporting year-on-year revenue growth [1][2] - Notably, Zhuozhao Adhesive achieved the highest revenue growth rate at 207.46%, while several other companies, including Xingbo Biology and Mingyang Technology, also reported revenue growth exceeding 30% [1][2] Revenue Growth - Zhuozhao Adhesive reported a revenue of 156 million yuan, marking a year-on-year increase of 207.46% and a net profit of 26.78 million yuan, recovering from a loss of 12.03 million yuan in the same period last year [2] - The revenue growth for Zhuozhao Adhesive was attributed to increased demand in end-use applications, accelerated acceptance of existing projects, progress in new market development, and improved cost control and operational efficiency [2] - Xingbo Biology achieved a revenue of 2.966 billion yuan, with a year-on-year growth of 3.04%, and a net profit of 15.29 million yuan, recovering from a loss of 79.38 million yuan last year [3] - Haineng Technology reported total revenue of 136 million yuan, a year-on-year increase of 34.87%, and a net profit of 5.47 million yuan, recovering from a loss of 14.01 million yuan in the previous year [3] Dividend Distribution - Zhuozhao Adhesive, Xingbo Biology, and other companies plan to distribute a total cash dividend of 176 million yuan [4] - Zhuozhao Adhesive announced a cash dividend of 2.20 yuan per 10 shares, totaling approximately 18.06 million yuan [4] - Xingbo Biology plans to distribute a cash dividend of 10 yuan per 10 shares, amounting to about 115 million yuan [4] - Mingyang Technology intends to distribute a cash dividend of 2.25 yuan per 10 shares, totaling around 3 million yuan [4] - Jianbang Technology announced a cash dividend of 2 yuan per 10 shares, totaling approximately 1.32 million yuan [5]